Screening for Breast Cancer
JAMA · 11.06.2024 · 331 (22) · 1918
DOI: 10.1001/jama.2024.5534 ↗Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 11.06.2024. Verfasst von US Preventive Services Task Force und 18 weiteren Autor:innen. Beteiligte Einrichtung: George Washington University, Washington, DC. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammography, Early Detection of Cancer. Die Arbeit wurde bisher 516-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Importance Among all US women, breast cancer is the second most common cancer and the second most common cause of cancer death. In 2023, an estimated 43 170 women died of breast cancer. Non-Hispanic White women have the highest incidence of breast cancer and non-Hispanic Black women have the highest mortality rate. Objective The USPSTF commissioned a systematic review to evaluate the comparative effectiveness of different mammography-based breast cancer screening strategies by age to start and stop screening, screening interval, modality, use of supplemental imaging, or personalization of screening for breast cancer on the incidence of and progression to advanced breast cancer, breast cancer morbidity, and breast cancer–specific or all-cause mortality, and collaborative modeling studies to complement the evidence from the review. Population Cisgender women and all other persons assigned female at birth aged 40 years or older at average risk of breast cancer. Evidence Assessment The USPSTF concludes with moderate certainty that biennial screening mammography in women aged 40 to 74 years has a moderate net benefit. The USPSTF concludes that the evidence is insufficient to determine the balance of benefits and harms of screening mammography in women 75 years or older and the balance of benefits and harms of supplemental screening for breast cancer with breast ultrasound or magnetic resonance imaging (MRI), regardless of breast density. Recommendation The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of supplemental screening for breast cancer using breast ultrasonography or MRI in women identified to have dense breasts on an otherwise negative screening mammogram. (I statement)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- George Washington University, Washington, DC.
- Brown University, Providence, Rhode Island.
- Tufts University School of Medicine, Boston, Massachusetts.
- Harvard Medical School, Boston, Massachusetts.
- Virginia Commonwealth University, Richmond.
- University of Washington, Seattle.
Förderung
- NIA NIH HHS
Zitieren
APA
US Preventive Services Task Force, Nicholson, W. K., Silverstein, M., Wong, J. B., Barry, M. J., Chelmow, D., Coker, T. R., Davis, E. M., Jaén, C. R., Krousel-Wood, M., Lee, S., Li, L., Mangione, C. M., Rao, G., Ruiz, J. M., Stevermer, J. J., Tsevat, J., Underwood, S. M., & Wiehe, S. (2024). Screening for Breast Cancer. JAMA, 331(22), 1918. https://doi.org/10.1001/jama.2024.5534
Vancouver
US Preventive Services Task Force, Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al. Screening for Breast Cancer. JAMA. 2024;331(22):1918. doi:10.1001/jama.2024.5534
BibTeX
@article{USPreventiveServicesTaskForce2024,
author = {US Preventive Services Task Force, US Preventive Services Task Force and Nicholson, Wanda K and Silverstein, Michael and Wong, John B and Barry, Michael J and Chelmow, David and Coker, Tumaini Rucker and Davis, Esa M and Jaén, Carlos Roberto and Krousel-Wood, Marie and Lee, Sei and Li, Li and Mangione, Carol M and Rao, Goutham and Ruiz, John M and Stevermer, James J and Tsevat, Joel and Underwood, Sandra Millon and Wiehe, Sarah},
title = {Screening for Breast Cancer},
journal = {JAMA},
year = {2024},
volume = {331},
number = {22},
pages = {1918},
doi = {10.1001/jama.2024.5534}
}
EUVIMED